[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 2, Issue 2 (1-2011) ::
Caspian J Intern Med 2011, 2(2): 213-217 Back to browse issues page
Metabolic capacity of CYP2D6 within an Iranian population (Mazandaran Province)
Shiran Mohammad Reza *, Fatemeh Sarzare, Fatemeh Merat, Ebrahim Salehifar, Ali Akbar Moghadamnia, Seyed Mohammad Bagher Hashemi Soteh
Abstract:   (7325 Views)
Background: CYP2D6 is polymorphically expressed enzyme that show marked interindividual and interethnic variation. Phenotyping of CYP2D6 provides valuable information about real-time activity of this important drug-metabolizing enzymes through the use of specific probe drugs. The aim of this study was to identify the CYP2D6 oxidation phenotype with dextromethorphan (DEX) as a probe drug in Mazandarani ethnic group among Iranian population.
Methods: The study included 71 unrelated healthy volunteers. Dextromethorphan hydrobromide (30 mg) was given orally to healthy subjects and peripheral venous blood samples (10 ml) were taken at 3 hr post-dose. Dextromethorphan and the metabolite dextrorphan (DOR) were analyzed by the HPLC method. The log DEX/DOR metabolic ratio (MR) at 3 hr plasma sample was used as the index of CYP2D6 activity and a value of 0.3 was used as the antimode separating extensive metabolizers (EM) and poor metabolizers (PM) phenotypes.
Results: A 560-fold interindividual variation in dextromethorphan MRs was observed in this study. Considering the antimode 0.3 in log scale, 7.04% (5/71) volunteers were identified as PMs.
Conclusion: The result showed that the frequency of CYP2D6 PM phenotypes accounted for 7.04% of subjects in our samples. Despite these findings, we propose a further study in larger samples to provide a wider image and to get more valuable information upon pharmacogenetic basis for individual therapy and personalized medicine.
Keywords: Phenotype, Polymorphism, CYP2D6, Dextromethorphan, Mazandaran, Iran
Full-Text [PDF 123 kb]   (1759 Downloads)    
Type of Study: Original Article | Subject: Infectious Diseases
Received: 2014/01/14 | Accepted: 2014/01/14 | Published: 2014/01/14
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammad Reza S, Sarzare F, Merat F, Salehifar E, Moghadamnia A A, Hashemi Soteh S M B. Metabolic capacity of CYP2D6 within an Iranian population (Mazandaran Province). Caspian J Intern Med. 2011; 2 (2) :213-217
URL: http://caspjim.com/article-1-104-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 2, Issue 2 (1-2011) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4341